Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort by Idahl, A, Le Cornet, C, González Maldonado, S, Perez-Cornago, A, Et al.

Prognostic role of pre-diagnostic circulating inflammatory biomarkers in breast cancer survival: evidence from the EPIC cohort study by Castro-Espin, C, Cairat, M, Navionis, A, Dahm, CC, Antoniussen, CS, Tjønneland, A, Mellemkjær, L, Mancini, FR, Hajji-Louati, M, Severi, G, Le Cornet, C, Kaaks, R, Schulze, MB, Masala, G, Agnoli, C, Sacerdote, C, Crous-Bou, M, Sánchez, M, Amiano, P, Chirlaque, M, Guevara, M, Smith-Byrne, K, Heath, AK, Christakoudi, S

Are circulating immune cells a determinant of pancreatic cancer risk? A prospective study using epigenetic cell count measures by Katzke, V, Le Cornet, C, Mahfouz, R, Brauer, B, Johnson, T, Canzian, F, Rebours, V, Boutron-Ruault, M-C, Severi, G, Schulze, MB, Olsen, A, Tjoenneland, A, Overvad, K, Crous-Bou, M, Molina-Montes, E, Amiano, P, Huerta, JM, Ardanaz, E, Perez-Cornago, A, Masala, G, Pala, V, Tumino, R, Sacerdote, C, Panico, S, Bueno-de-Mesquita, B, Vermeulen, R, Sund, M, Franklin, O, Christakoudi, S, Dossus, L, Weiderpass, E, Olek, S, Kaaks, R